Composite endpoints, including patient reported outcomes, in rare diseases.
Johan VerbeeckMaya DiraniJohann W BauerRalf-Dieter HilgersGeert MolenberghsRima NabboutPublished in: Orphanet journal of rare diseases (2023)
Generalized pairwise comparisons is a promising statistical methodology for evaluating any type of composite endpoints in rare disease trials and may allow a better evaluation of therapy efficacy including patients reported outcomes in addition to outcomes related to the diseases signs and symptoms.